ABSTRACT
PURPOSE: This study investigates the accuracy of either computerized tomography (CT) or magnetic resonance imaging (MRI) for the evaluation of various orbital diseases. METHODS: We collected 126 CT scans and 65 MRI scans from 144 subjects and asked two radiologists to interpret the images without clinical information. Images included 14 with a clinical diagnosis of orbital infection, 144 with orbital inflammation, and 33 with orbital neoplasm. The inflammatory diseases included thyroid eye disease (TED, n = 69), non-specific orbital inflammation (NSOI, n = 44), IgG4-related disease (IgG4-RD, n = 15), sarcoidosis (Sarcoid, n = 9), granulomatosis with polyangiitis (GPA, n = 5), and Erdheim-Chester disease (ECD, n = 2). RESULTS: The balanced accuracy (BA) for the two radiologists ranged from 0.87 to 0.90 for cellulitis, 0.81 to 0.86 for inflammation, and 0.82 to 0.85 for neoplasm. Radiologists were excellent at recognizing GPA (BA = 0.98 to 0.99) and very good for TED (BA = 0.80 to 0.86). They also did well identifying IgG4-RD (BA = 0.75 to 0.77), but slightly less well for NSOI (BA = 0.69 to 0.75) and poorly for Sarcoid (BA = 0.48 to 0.50). CONCLUSIONS: CT or MRI scanning contributes to the evaluation of patients with orbital disease, but accuracy does varies based depending on the diagnosis. We could not evaluate issues such as determination of disease activity, variability based on the unit used for imaging or the skills beyond those of our two specialized neuroradiologists. Future studies should directly compare the two imaging modalities and assess the utility of imaging to determine disease activity.
Subject(s)
Magnetic Resonance Imaging , Orbital Diseases , Tomography, X-Ray Computed , Humans , Magnetic Resonance Imaging/methods , Tomography, X-Ray Computed/methods , Male , Female , Middle Aged , Adult , Orbital Diseases/diagnostic imaging , Orbital Diseases/pathology , Aged , Sarcoidosis/diagnostic imaging , Orbit/diagnostic imaging , Orbit/pathology , Granulomatosis with Polyangiitis/diagnostic imaging , Granulomatosis with Polyangiitis/diagnosis , Young Adult , Aged, 80 and over , AdolescentABSTRACT
PURPOSE OF REVIEW: Evolving understanding of thyroid eye disease (TED) has led to rapidly advancing therapeutic options. Most new treatments under development or recently available to patients are predicated on insights into disease mechanism. RECENT FINDINGS: TED, a disfiguring process, involves inflammation and remodeling of the connective tissues around the eye. TED most frequently presents as a component of Graves' disease. Advances in our understanding of cells involved in TED and their molecular interactions have led to novel therapeutic targets. Among these cell types are orbital fibroblasts and a subset comprising monocyte progenitor cells, known as CD34 + CXCR4 + fibrocytes. Among the attributes of fibrocytes is their expression of several autoantigens associated with Graves' disease, including TSHR, thyroglobulin and thyroperoxidase. Fibrocytes also express high levels of the insulin-like growth factor-I (IGF-I) receptor, thought to mediate fibroblast activation. Therapeutically targeting the TSHR/IGF-IR receptor complex using an IGF-I receptor antagonist, teprotumumab, has resulted in substantial clinical benefit for patients with TED. The neural axon repellent, Slit2, and its cognate receptor, ROBO1, appear to modulate the inflammatory phenotype of these orbit-infiltrating fibrocytes. SUMMARY: More detailed understanding of orbital fibroblasts and the distinctions between cell subsets comprising them should lead to more effective therapies with fewer side effects.
Subject(s)
Fibroblasts , Graves Ophthalmopathy , Orbit , Receptor, IGF Type 1 , Receptors, Thyrotropin , Humans , Graves Ophthalmopathy/metabolism , Graves Ophthalmopathy/drug therapy , Receptors, Thyrotropin/metabolism , Fibroblasts/metabolism , Receptor, IGF Type 1/metabolism , Orbit/pathology , Antibodies, Monoclonal, Humanized/therapeutic useABSTRACT
A patient in his 20s presented with a change in the appearance of his left eye with evidence of relative afferent pupillary defect. Imaging revealed a giant frontoethmoidal osteoma, a benign sinonasal tumour, invading three-quarters of the orbit. Multidisciplinary discussion involving opthalmology, maxillofacial surgery, neurosurgery and otolaryngology resulted in the decision to attempt entirely endoscopic excision of this lesion, which was performed with successful outcomes. This case demonstrates how a sinonasal osteoma should be considered in the differential diagnosis for a patient presenting with proptosis or other eye signs suggestive of compression of the orbital compartment. This case report and literature review highlights the possibility of managing giant sinonasal osteomas with orbital extension through a completely endoscopic approach.
Subject(s)
Endoscopy , Osteoma , Paranasal Sinus Neoplasms , Humans , Osteoma/surgery , Osteoma/diagnostic imaging , Osteoma/pathology , Male , Endoscopy/methods , Paranasal Sinus Neoplasms/surgery , Paranasal Sinus Neoplasms/diagnostic imaging , Paranasal Sinus Neoplasms/pathology , Ethmoid Bone/diagnostic imaging , Ethmoid Bone/surgery , Ethmoid Bone/pathology , Orbital Neoplasms/surgery , Orbital Neoplasms/diagnostic imaging , Orbital Neoplasms/pathology , Ethmoid Sinus/diagnostic imaging , Ethmoid Sinus/surgery , Ethmoid Sinus/pathology , Orbit/diagnostic imaging , Orbit/surgery , Orbit/pathology , Frontal Sinus/diagnostic imaging , Frontal Sinus/surgery , Frontal Sinus/pathology , Tomography, X-Ray Computed , Young Adult , Exophthalmos/etiology , Exophthalmos/surgery , Diagnosis, Differential , AdultABSTRACT
BACKGROUND: Sinonasal malignancies (SNMs) frequently present with orbital invasion. Orbital exenteration (OE) can lead to significant morbidity. Induction chemotherapy (IC) is a promising treatment alternative that may allow for orbit preserving (OP) treatments without compromising patient survival. This systematic review was conducted to synthesize the published data on SNM patients with orbital invasion who underwent IC, including tumor response, orbital outcomes, and survival. METHODS: The study protocol was designed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Databases Embase, Cochrane, Medline, and Scopus, from inception to July 17, 2023, were searched. RESULTS: Nineteen studies were included, encompassing 305 SNM patients with orbital invasion treated with IC. Fourteen studies reported an overall IC response rate (positive response defined as complete or partial tumor volume reduction) of 77.2%. Among included studies, OE rates after IC ranged from 0 to 40%. Three studies reported a high rate of posttreatment functional orbital preservation (89.8-96.0%). Five studies specifically reported that 62.5% (60 out of 96) of patients were downgraded from planned OE to OP treatment following IC. Three studies reported a significant overall survival (OS) improvement in IC responders versus IC nonresponders. Following IC, 5-year OS ranged from 44.2 to 55.5%. Patients with olfactory neuroblastoma demonstrated the highest IC response rate and lowest OE rate (100 and 0%, respectively) versus those with sinonasal undifferentiated carcinomas (68.4 and 0%) or squamous cell carcinomas (76.7 and 16%). CONCLUSIONS: For select patients, IC may allow for OP in locally advanced SNMs with orbital involvement.
Subject(s)
Induction Chemotherapy , Orbital Neoplasms , Paranasal Sinus Neoplasms , Humans , Paranasal Sinus Neoplasms/drug therapy , Paranasal Sinus Neoplasms/pathology , Orbital Neoplasms/drug therapy , Orbital Neoplasms/pathology , Neoplasm Invasiveness , Treatment Outcome , Orbit/pathologyABSTRACT
Interleukin-2-inducible tyrosine kinase (ITK) is a crucial cytoplasmic protein in the T-cell signaling pathway. Here, we aimed to demonstrate the anti-inflammatory effect of the selective IL-2-induced tyrosine kinase inhibitor BMS-509744 (BMS) on Graves' orbitopathy (GO) in an in vitro model. ITK mRNA expression in orbital tissues from GO and normal controls was compared using real-time polymerase chain reaction (RT-PCR) and immunohistochemistry. Primary cultured orbital fibroblasts from each group were pretreated with BMS and stimulated with interleukin (IL)-1ß to induce inflammatory reaction. ITK mRNA expression was evaluated using western blotting, and inflammatory cytokine production and downstream transcription factor expression were analyzed after pretreatment with BMS. ITK mRNA expression in GO tissues was significantly higher than that in normal control tissues. After stimulation with IL-1ß, ITK phosphorylation significantly increased in both GO orbital and normal control tissues. BMS inhibited IL-1ß-induced IL-8 expression in the GO orbital fibroblasts. BMS pretreatment significantly suppressed NF-κB phosphorylation in both GO and normal controls. The selective ITK inhibitor attenuates proinflammatory cytokine production and proinflammatory transcription factor phosphorylation in in vitro model of GO.
Subject(s)
Fibroblasts , Graves Ophthalmopathy , Orbit , Protein-Tyrosine Kinases , Humans , Graves Ophthalmopathy/drug therapy , Graves Ophthalmopathy/metabolism , Graves Ophthalmopathy/pathology , Fibroblasts/drug effects , Fibroblasts/metabolism , Protein-Tyrosine Kinases/antagonists & inhibitors , Protein-Tyrosine Kinases/metabolism , Female , Male , Orbit/pathology , Orbit/drug effects , Middle Aged , Cells, Cultured , Adult , Protein Kinase Inhibitors/pharmacology , Interleukin-1beta/metabolism , Phosphorylation/drug effectsABSTRACT
BACKGROUND: The pathogenesis of thyroid-associated orbitopathy (TAO) remains incompletely understand. The interaction between immunocytes and orbital fibroblasts (OFs) play a critical role in orbital inflammatory and fibrosis. Accumulating reports indicate that a significant portion of plasma exosomes (Pla-Exos) are derived from immune cells; however, their impact upon OFs function is unclear. METHODS: OFs were primary cultured from inactive TAO patients. Exosomes isolated from plasma samples of patients with active TAO and healthy controls (HCs) were utilized for functional and RNA cargo analysis. Functional analysis in thymocyte differentiation antigen-1+ (Thy-1+) OFs measured expression of inflammatory and fibrotic markers (mRNAs and proteins) and cell activity in response to Pla-Exos. RNA cargo analysis was performed by RNA sequencing and RT-qPCR. Thy-1+ OFs were transfected with miR-144-3p mimics/inhibitors to evaluate its regulation of inflammation, fibrosis, and proliferation. RESULTS: Pla-Exos derived from active TAO patients (Pla-ExosTAO-A) induced stronger production of inflammatory cytokines and hyaluronic acid (HA) in Thy-1+ OFs while inhibiting their proliferation. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis and single sample gene set enrichment analysis (ssGSEA) suggested that the difference in mRNA expression levels between Pla-ExosTAO-A and Pla-ExosHC was closely related to immune cells. Differential expression analysis revealed that 62 upregulated and 45 downregulated miRNAs in Pla-ExosTAO-A, with the elevation of miR-144-3p in both Pla-Exos and PBMCs in active TAO group. KEGG analysis revealed that the target genes of differentially expressed miRNA and miR-144-3p enriched in immune-related signaling pathways. Overexpression of the miR-144-3p mimic significantly upregulated the secretion of inflammatory cytokines and HA in Thy-1+ OFs while inhibiting their proliferation. CONCLUSION: Pla-Exos derived from patients with active TAO were immune-active, which may be a long-term stimulus casual for inflammatory and fibrotic progression of TAO. Our finding suggests that Pla-Exos could be used as biomarkers or treatment targets in TAO patients.
Subject(s)
Exosomes , Fibroblasts , Fibrosis , Graves Ophthalmopathy , Inflammation , MicroRNAs , Orbit , Humans , Exosomes/metabolism , Graves Ophthalmopathy/pathology , Graves Ophthalmopathy/blood , Graves Ophthalmopathy/genetics , MicroRNAs/genetics , MicroRNAs/metabolism , MicroRNAs/blood , Fibroblasts/metabolism , Fibroblasts/pathology , Orbit/pathology , Inflammation/pathology , Female , Male , Cell Proliferation , Middle Aged , Adult , Hyaluronic Acid/blood , Hyaluronic Acid/metabolism , Cytokines/metabolism , Thy-1 Antigens/metabolismABSTRACT
This investigation sought to ascertain whether orbital morphology could predict genuine metopic craniosynostosis (MCS). The study retrospectively analyzed preoperative three-dimensional computed tomography (3D-CT) scans of patients who underwent surgical correction for MCS. MCS severity was evaluated using the interfrontal angle (IFA). Orbital dysmorphology was assessed based on multiple angles, including supraorbital notches and nasion (SNS), infraorbital foramina and nasion (INI), zygomaticofrontal suture-supraorbital notch-dacryon (ZSD), and orbital long axis (OLA). Results were juxtaposed against age/gender-matched controls and individuals with non-synostotic metopic ridge (MR). The study included 177 patients: 68 MCS, 35 MR, and 74 control subjects. All orbital measurements exhibited significant differences across groups. IFA demonstrated a strong association with all orbital measurements, particularly SNS (B = 0.79, p < 0.001). SNS showed the highest area under the curve among orbital measurements (0.89). Using a 95% sensitivity threshold, the optimal diagnostic angle for SNS was 129.23° (specificity 54%, sensitivity 96%). These findings suggest a correlation between orbital dysmorphology and trigonocephaly severity. The observed dysmorphology manifested in a superomedially accentuated rotational pattern. Importantly, SNS angle predicted MCS, with an angle greater than 130° indicating <5% likelihood of MCS diagnosis. The simplicity of measuring SNS angle on any 3D-CT scan highlights its practical use for assisting with MCS diagnosis.
Subject(s)
Craniosynostoses , Imaging, Three-Dimensional , Orbit , Tomography, X-Ray Computed , Humans , Craniosynostoses/diagnostic imaging , Craniosynostoses/surgery , Retrospective Studies , Orbit/diagnostic imaging , Orbit/pathology , Male , Female , Tomography, X-Ray Computed/methods , Imaging, Three-Dimensional/methods , Infant , Child, Preschool , Case-Control StudiesABSTRACT
OBJECTIVE: Metopic craniosynostosis (MCS) can be difficult to differentiate from metopic ridge (MR) or normal frontal morphology. This study assess whether the supraorbital notch-nasion-supraorbital notch (SNS) angle can help identify MCS. METHODS: Records of 212 patients with preoperative three-dimensional computed tomography scans were examined. The SNS angles, surgeon craniofacial dysmorphology rankings, and CranioRate metopic severity scores (MSSs) were compared with the Spearman rank correlation coefficient. Receiver operating characteristic (ROC) curves with Youden J-statistic and cross-validation of regression models assessed the ability of these measures to predict surgery. RESULTS: A total of 212 patients were included, consisting of 78 MCS, 37 MR, and 97 controls. Both the mean SNS angle (MCS: 111.7 ± 10.7 degrees, MR: 126.0 ± 8.2 degrees, controls: 130.7 ± 8.8 degrees P < 0.001) and MSS (MCS: 5.9 ± 2.0, MR: 1.4 ± 1.9, controls: 0.2 ± 1.9, P < 0.001) were different among the cohorts. The mean SNS angle (111.5 ± 10.7 versus 129.1 ± 8.8, P < 0.001) was lower in those who had surgery and CranioRate score (5.9 ± 2.1 versus 0.8 ± 2.2, P < 0.001) was higher in those who underwent surgery. SNS angles were positively correlated with surgeon craniofacial dysmorphology rankings ( r = 0.41, P < 0.05) and CranioRate MSS ( r = 0.54, P < 0.05). The ROC curve requiring high sensitivity revealed an SNS angle of 124.8 degrees predicted surgery with a sensitivity of 88.7% and a specificity of 71.3%. A ROC curve using the CranioRate MCC values ≥3.19 predicted surgery with 88.7% sensitivity and 94.7% specificity. CONCLUSION: Orbital dysmorphology in patients with MCS is well captured by the supraorbital-nasion angle. Both the SNS angle and CranioRate MSS scores accurately predict surgical intervention.
Subject(s)
Craniosynostoses , Tomography, X-Ray Computed , Female , Humans , Infant , Male , Craniosynostoses/surgery , Craniosynostoses/diagnostic imaging , Imaging, Three-Dimensional , Orbit/diagnostic imaging , Orbit/pathology , Reproducibility of Results , Retrospective Studies , ROC Curve , Severity of Illness IndexABSTRACT
BACKGROUND: Orbital involvement of invasive fungal sinusitis (IFS) is an ominous prognostic marker that should prompt rapid intervention. Transcutaneous retrobulbar administration of amphotericin B (TRAMB) is an off-label adjunctive treatment that can increase drug penetrance into diseased orbital tissue. To date, there is a lack of consensus regarding the use of TRAMB for treatment of IFS with orbital involvement. OBJECTIVE: This systematic review aims to synthesize the indications, efficacy, and potential complications of TRAMB. METHODS: PubMed, EMBASE, and Web of Science databases were probed for systematic review. Article search was conducted through June 2023 using the keywords "invasive fungal sinusitis," "invasive fungal rhinosinusitis," "rhino-orbital mucormycosis," "rhinosinusitis," "orbital," "retrobulbar," and "amphotericin." RESULTS: In suitable cases as determined by radiologic and clinical evaluation, TRAMB administration has the potential to improve orbital salvage rates and improve versus stabilize visual acuity. Treatment complications are more likely with deoxycholate than with liposomal amphotericin formulations. The existing literature describing use of TRAMB is limited due to its retrospective nature, but the increase in IFS cases since 2020 due to the COVID pandemic has broadened the literature. CONCLUSIONS: TRAMB is an effective adjunctive treatment in IFS with mild-to-moderate orbital involvement when used in combination with standard of care debridement, systemic antifungal therapy, and immunosuppression reversal. Prospective longitudinal studies and multi-institutional randomized trials are necessary to determine the definitive utility of TRAMB.
Subject(s)
Amphotericin B , Antifungal Agents , Invasive Fungal Infections , Sinusitis , Humans , Amphotericin B/administration & dosage , Amphotericin B/therapeutic use , Sinusitis/drug therapy , Antifungal Agents/administration & dosage , Antifungal Agents/therapeutic use , Invasive Fungal Infections/drug therapy , Invasive Fungal Infections/diagnosis , COVID-19/complications , Orbital Diseases/drug therapy , Orbital Diseases/etiology , Orbital Diseases/diagnosis , Mucormycosis/drug therapy , Mucormycosis/diagnosis , Rhinitis/drug therapy , Rhinitis/microbiology , SARS-CoV-2 , Orbit/pathology , Administration, CutaneousABSTRACT
PURPOSE: This study aimed to explore the diagnostic value of whole-orbit-based multiparametric assessment on Dixon MRI for the evaluation of the thyroid eye disease (TED) activity. METHODS: The retrospective study enrolled patients diagnosed as TED and obtained their axial and coronal Dixon MRI scans. Multiparameters were assessed, including water fraction (WF), fat fraction (FF) of extraocular muscles (EOMs), orbital fat (OF), and lacrimal gland (LG). The thickness of OF and herniation of LG were also measured. Univariable and multivariable logistic regression was applied to construct prediction models based on single or multiple structures. Receiver operating characteristic (ROC) curve analysis was also implemented. RESULTS: Univariable logistic analysis revealed significant differences in water fraction (WF) of the superior rectus (P = 0.018), fat fraction (FF) of the medial rectus (P = 0.029), WF of OF (P = 0.004), and herniation of LG (P = 0.012) between the active and inactive TED phases. Multivariable logistic analysis and corresponding receiver operating characteristic curve (ROC) analysis of each structure attained the area under the curve (AUC) values of 0.774, 0.771, and 0.729 for EOMs, OF, and LG, respectively, while the combination of the four imaging parameters generated a final AUC of 0.909. CONCLUSIONS: Dixon MRI may be used for fine multiparametric assessment of multiple orbital structures. The whole-orbit-based model improves the diagnostic performance of TED activity evaluation.
Subject(s)
Graves Ophthalmopathy , Oculomotor Muscles , Orbit , ROC Curve , Humans , Male , Female , Graves Ophthalmopathy/diagnosis , Graves Ophthalmopathy/diagnostic imaging , Retrospective Studies , Middle Aged , Orbit/diagnostic imaging , Orbit/pathology , Oculomotor Muscles/diagnostic imaging , Oculomotor Muscles/pathology , Adult , Aged , Multiparametric Magnetic Resonance Imaging/methods , Magnetic Resonance Imaging/methods , Lacrimal Apparatus/diagnostic imaging , Lacrimal Apparatus/pathologyABSTRACT
Orbital connective tissue changes are contributors to the pathogenesis in thyroid eye disease (TED). Activated fibroblasts respond to immune stimuli with proliferation and increased hyaluronan (HA) production. Cyclosporin A (CsA) was reported to be beneficial in the treatment of TED. PDGF isoforms are increased in orbital tissue of TED patients and enhance HA production. We aimed to study the effect of CsA on HA production and hyaluronan synthase (HAS1, 2 and 3) and hyaluronidase (HYAL1 and 2) mRNA expressions in orbital fibroblasts (OFs). Measurements were performed in the presence or absence of CsA (10 µM) in unstimulated or PDGF-BB (10 ng/ml) stimulated OFs. The HA production of TED OFs (n = 7) and NON-TED OFs (n = 6) were measured by ELISA. The levels of mRNA expressions were examined using RT-PCR. The proliferation rate and metabolic activity were measured by BrdU incorporation and MTT assays, respectively. Treatment with CsA resulted in an average 42% decrease in HA production of OFs (p < 0.0001). CsA decreased the expression levels of HAS2, HAS3 and HYAL2 (p = 0.005, p = 0.005 and p = 0.002, respectively.) PDGF-BB increased HA production (p < 0.001) and HAS2 expression (p = 0.004). CsA could reduce the PDGF-BB-stimulated HA production (p < 0.001) and HAS2 expression (p = 0.005) below the untreated level. In addition, CsA treatment caused a decrease in proliferation potential (p = 0.002) and metabolic activity (p < 0.0001). These findings point to the fact that CsA affects HA metabolism via HAS2, HAS3 and HYAL2 inhibition in OFs. In addition to its well characterized immunosuppressant properties, CsA's beneficial effect in TED may be related to its direct inhibitory effect on basal and growth factor stimulated HA production.
Subject(s)
Becaplermin , Cell Proliferation , Cyclosporine , Fibroblasts , Glucuronosyltransferase , Graves Ophthalmopathy , Hyaluronan Synthases , Hyaluronic Acid , Hyaluronoglucosaminidase , Proto-Oncogene Proteins c-sis , Hyaluronic Acid/biosynthesis , Hyaluronic Acid/pharmacology , Humans , Becaplermin/metabolism , Becaplermin/pharmacology , Fibroblasts/drug effects , Fibroblasts/metabolism , Hyaluronan Synthases/metabolism , Hyaluronan Synthases/genetics , Cyclosporine/pharmacology , Hyaluronoglucosaminidase/metabolism , Hyaluronoglucosaminidase/antagonists & inhibitors , Cell Proliferation/drug effects , Proto-Oncogene Proteins c-sis/metabolism , Glucuronosyltransferase/metabolism , Glucuronosyltransferase/genetics , Graves Ophthalmopathy/metabolism , Graves Ophthalmopathy/pathology , Graves Ophthalmopathy/drug therapy , Cells, Cultured , Orbit/metabolism , Orbit/drug effects , Orbit/pathology , RNA, Messenger/metabolism , RNA, Messenger/genetics , Cell Adhesion Molecules/metabolism , GPI-Linked ProteinsABSTRACT
Cavernous hemangioma, currently known as "cavernous venous malformation," is a common, benign, non-infiltrative, slowly progressive vascular malformation of the orbit presenting in adults. We report the case of a 9-year-old girl who presented with a painless palpable mass over the right upper eyelid of 7 years' duration. A computed tomography scan of the orbits revealed a heterogeneously enhancing, well-circumscribed mass in the right upper eyelid with no orbital extension. A transcutaneous excisional biopsy with histopathology disclosed cavernous venous malformation. The majority of cavernous venous malformations are intraconal and present in the fourth to fifth decade of life.
Subject(s)
Hemangioma, Cavernous , Orbital Neoplasms , Vascular Malformations , Adult , Female , Humans , Child , Orbital Neoplasms/pathology , Hemangioma, Cavernous/diagnosis , Hemangioma, Cavernous/surgery , Hemangioma, Cavernous/pathology , Orbit/pathology , Vascular Malformations/diagnosis , Eyelids/pathologyABSTRACT
Graves' ophthalmopathy (GO) is an extra-thyroidal complication of Graves' disease which can lead to vision loss in severe cases. Currently, treatments of GO are not sufficiently effective, so novel therapeutic strategies are needed. As platelet-derived growth factor (PDGF)-BB induces several effector mechanisms in GO orbital fibroblasts including cytokine production and myofibroblast activation, this study aims to investigate the roles of histone lysine methyltransferases (HKMTs) in PDGF-BB-activated GO orbital fibroblasts by screening with HKMTs inhibitors library. From the total of twelve selective HKMT inhibitors in the library, EZH2, G9a and DOT1L inhibitors, DZNeP, BIX01294 and Pinometostat, respectively, prevented PDGF-BB-induced proliferation and hyaluronan production by GO orbital fibroblasts. However, only EZH2 inhibitor, DZNeP, significantly blocked pro-inflammatory cytokine production. For the HKMTs expression in GO orbital fibroblasts, PDGF-BB significantly and time-dependently induced EZH2, G9a and DOT1L mRNA expression. To confirm the role of EZH2 in PDGF-BB-induced orbital fibroblast activation, EZH2 silencing experiments revealed suppression of PDGF-BB-induced collagen type I and α-SMA expression along with decreasing histone H3 lysine 27 trimethylation (H3K27me3) level. In a more clinically relevant model than orbital fibroblast culture experiments, DZNeP treated GO orbital tissues significantly reduced pro-inflammatory cytokine production while slightly reduced ACTA2 mRNA expression. Our data is the first to demonstrate that among all HKMTs EZH2 dominantly involved in the expression of myofibroblast markers in PDGF-BB-activated orbital fibroblast from GO presumably via H3K27me3. Thus, EZH2 may represent a novel therapeutics target for GO.
Subject(s)
Graves Ophthalmopathy , Histones , Humans , Becaplermin/metabolism , Proto-Oncogene Proteins c-sis/genetics , Histone Methyltransferases/metabolism , Histones/metabolism , Lysine/metabolism , Orbit/pathology , Graves Ophthalmopathy/metabolism , Cytokines/metabolism , Fibroblasts/metabolism , RNA, Messenger/genetics , Cells, Cultured , Enhancer of Zeste Homolog 2 Protein/genetics , Enhancer of Zeste Homolog 2 Protein/metabolismABSTRACT
RATIONALE: Eosinophilic angiocentric fibrosis (EAF) is considered to be a kind of benign IgG4-related disease, and it is more often found in the nasal cavity. We present a pretty rare case of orbital EAF that is unlike any other reported case for this case is an IgG4 negative orbital EAF and successfully treated by the fronto orbitozygomatic approach surgery. PATIENT CONCERNS: This is a 68-year-old man from a rural area of Inner Mongolia Autonomous Region, went to our hospital for a 2-month history of vision loss with a local hospital orbital computer tomography which showed that there was a lesion in his left orbit. The inspection of the patient revealed that the patient left eye was protruding outward and the left eyelid unable to complete open or close. And his left eyeball movement had difficulty in all directions. Postoperative pathology diagnosed that this was a case of IgG4-negative EAF case. DIAGNOSES: Orbital EAF. INTERVENTIONS: Surgical radical resection and postoperative glucocorticoid therapy. OUTCOMES: After surgery, the left eye vision of this patient increased to 0.6 tested in the standard logarithmic visual acuity chart. And his left eyeball movement dysfunction and eyeball outward protruding get a partially relief. LESSONS: EAF occurring in the orbit is a very rare disease and immunohistochemical results of EAF can be IgG4 negative.
Subject(s)
Orbit , Tomography, X-Ray Computed , Male , Humans , Aged , Fibrosis , Orbit/diagnostic imaging , Orbit/surgery , Orbit/pathology , Tomography, X-Ray Computed/adverse effects , Vision Disorders/etiology , Immunoglobulin GABSTRACT
Vascular anomalies comprise a wide spectrum of clinical manifestations related to disturbances in the blood or lymph vessels. They correspond to mainly tumors (especially hemangiomas), characterized by high mitotic activity and proliferation of the vascular endothelium, and malformations, endowed with normal mitotic activity and no hypercellularity or changes in the rate of cell turnover. However, the classifications of these lesions go beyond this dichotomy and consist various systems adapted for and by different clinical subgroups. Thus, the classifications have not reached a consensus and have historically caused confusion regarding the nomenclatures and definitions. Cavernous venous malformations of the orbit, previously called cavernous hemangiomas, are the most common benign vascular orbital lesions in adults. Herein, we have compiled and discussed the various evidences, including clinical, radiological, morphological, and molecular evidence that indicate the non-neoplastic nature of these lesions.
Subject(s)
Hemangioma, Cavernous , Orbital Neoplasms , Humans , Hemangioma, Cavernous/diagnostic imaging , Hemangioma, Cavernous/pathology , Orbital Neoplasms/diagnostic imaging , Orbital Neoplasms/pathology , Orbit/blood supply , Orbit/diagnostic imaging , Orbit/pathology , Vascular Malformations/diagnostic imaging , Vascular Malformations/pathologySubject(s)
Giant Cell Arteritis , Aged , Humans , Cranial Nerve Diseases/etiology , Cranial Nerve Diseases/diagnostic imaging , Cranial Nerve Diseases/diagnosis , Giant Cell Arteritis/complications , Giant Cell Arteritis/diagnostic imaging , Oculomotor Nerve Diseases/etiology , Optic Nerve/diagnostic imaging , Optic Nerve/pathology , Orbit/diagnostic imaging , Orbit/pathologyABSTRACT
Thyroid orbitopathy (TO) is the most common cause of orbital tissue inflammation, accounting for about 60% of all orbital inflammations. The inflammatory activity and severity of TO should be diagnosed based on personal experience and according to standard diagnostic criteria. Magnetic resonance imaging (MRI) of the orbit is used not only to identify swelling and to differentiate inflammatory active from non-active TO, but also to exclude other pathologies, such as orbital tumours or vascular lesions. However, a group of diseases can mimic the clinical manifestations of TO, leading to serious diagnostic difficulties, especially when the patient has previously been diagnosed with a thyroid disorder. Diagnostic problems can be presented by cases of unilateral TO, unilateral or bilateral TO in patients with no previous or concomitant symptoms of thyroid disorders, lack of symptoms of eyelid retraction, divergent strabismus, diplopia as the only symptom of the disease, and history of increasing diplopia at the end of the day. The lack of visible efficacy of ongoing immunosuppressive treatment should also raise caution and lead to a differential diagnosis of TO. Differential diagnosis of TO and evaluation of its activity includes conditions leading to redness and/or swelling of the conjunctiva and/or eyelids, and other causes of ocular motility disorders and eye-setting disorders. In this paper, the authors review the most common diseases that can mimic TO or falsify the assessment of inflammatory activity of TO.
Subject(s)
Graves Ophthalmopathy , Humans , Graves Ophthalmopathy/diagnosis , Graves Ophthalmopathy/drug therapy , Diplopia/diagnosis , Diplopia/etiology , Diagnosis, Differential , Orbit/diagnostic imaging , Orbit/pathology , InflammationSubject(s)
Meningeal Neoplasms , Meningioma , Orbital Neoplasms , Humans , Meningioma/pathology , Meningioma/surgery , Meningioma/diagnostic imaging , Meningeal Neoplasms/pathology , Meningeal Neoplasms/diagnostic imaging , Meningeal Neoplasms/surgery , Orbital Neoplasms/pathology , Orbital Neoplasms/surgery , Orbital Neoplasms/diagnostic imaging , Neoplasm Invasiveness , Female , Magnetic Resonance Imaging , Orbit/pathology , Orbit/diagnostic imaging , Middle AgedABSTRACT
A case is presented of a 43-year-old male with a chronic history of progressive nasal obstruction and epiphora. MRI confirmed a heterogeneous mass involving the middle and superior turbinates with T2 hyperintense and calcified components, with extension into the inferomedial orbit. Tissue biopsy revealed a grade 2 chondrosarcoma of the conventional subtype. Endonasal wide local resection of the lesion was performed with clear margins. The patient had no functional sequelae and will undergo routine surveillance.
Subject(s)
Chondrosarcoma , Magnetic Resonance Imaging , Orbital Neoplasms , Paranasal Sinus Neoplasms , Humans , Male , Chondrosarcoma/diagnosis , Chondrosarcoma/surgery , Chondrosarcoma/pathology , Adult , Orbital Neoplasms/diagnosis , Orbital Neoplasms/surgery , Orbital Neoplasms/pathology , Paranasal Sinus Neoplasms/pathology , Paranasal Sinus Neoplasms/diagnosis , Paranasal Sinus Neoplasms/surgery , Neoplasm Invasiveness , Biopsy , Tomography, X-Ray Computed , Orbit/pathology , Orbit/diagnostic imagingABSTRACT
ABSTRACT: We report an unusual presentation of an orbital spindle cell hemangioma in a 40-year-old male, who noted sudden redness and swelling of the left eye on waking up. On examination, the patient was found to have edema of upper eyelid edema, periorbital ecchymosis, and subconjunctival hemorrhage in the left eye at presentation. On treatment with topical medications, patient had transient symptomatic relief; however, he later developed blurring of vision. When seen 10 days later, the patient's left eye showed axial proptosis. Radiological investigations revealed an intraconal soft tissue mass in the left medial rectus. Emergency orbital decompression with mass excision was done; histopathological examination of the excised mass revealed spindle cell hemangioma. Postsurgery patient had complete restoration of vision. To our knowledge, an acute presentation of an orbital hemangioma with subconjunctival hemorrhage and periorbital ecchymosis, visual loss doesn't occur commonly; hence, such presentations have to be reviewed with care.